Asia-Pacific healthcare is being pulled in opposite directions. Patients are asking for more convenience, more responsiveness and more preventive care; doctors are reporting heavier workloads, weak organisational support and burnout.

Bain & Company’s Asia-Pacific Front Line of Healthcare 2026 report, based on surveys of 6,300 consumers across nine markets in Asia Pacific and 600 doctors in Australia and the Philippines, describes a region where demand is rising faster than health systems can comfortably absorb.

The numbers are stark. Asia-Pacific has around 60% of the world’s population, but only 22% of global healthcare spending. In emerging Asia-Pacific countries, doctor density averages roughly 1.6 doctors per 1,000 people on a population-weighted basis. Excluding China, that falls to about 0.9 doctors per 1,000 people. Bain cites a World Health Organization benchmark of 2.5 physicians per 1,000 people; many OECD countries average 3.7.

Patients notice the gap as waiting. Doctors experience it as overload. Healthcare companies encounter it as a strategic problem: how to serve consumers who increasingly expect modern service standards, while relying on clinicians who are already stretched.

The report’s central message is not that Asia-Pacific healthcare is failing. It is that its operating model is under strain. The old bargain — patients wait, providers decide, paperwork accumulates — is becoming less durable.

The impatient patient

Healthcare consumers in Asia-Pacific are becoming more assertive. Bain found that 84% of consumers expect healthcare to be more convenient today than it was two years ago. Seventy-one percent expect doctors to be more responsive through phone, WhatsApp or email rather than requiring patients to wait for the next appointment.

This is not simply a preference for digital convenience. Consumers are also taking more active roles in managing their health. Sixty percent of those surveyed reported scheduling regular check-ups and screenings in 2025, up from 47% in 2023. China led the region, with 76% of consumers scheduling regular check-ups.

Spending behaviour has shifted too. Bain found net reported spending increases across every consumer health category it measured. Nutrition supplements recorded the largest net increase, at 43%, followed by fitness and exercise at 34%, and oral healthcare at 31%. That does not necessarily mean total expenditure rose by those exact percentages; it means that, in Bain’s survey, more consumers reported increasing than decreasing spending in those categories.

There is a practical reason for this consumer turn. Bain points to ageing populations and a growing chronic-disease burden as structural pressures on healthcare systems. Chronic care requires regular monitoring, prevention and coordination. It does not fit neatly into a model built around episodic visits and hospital-based intervention.

Yet the consumer experience remains frustrating. Long wait times remain one of the biggest patient pain points, consistent with Bain’s previous regional healthcare reports. Cost and complexity compound the problem. High out-of-pocket costs deter or delay care, and billing and coverage complexity erode trust. Among chronic patients, fewer than 70% report having regular check-ups, with high cost cited as the main barrier.

The patient may have acquired the expectations of a consumer. The system has not always acquired the habits of a service industry.

The doctor shortage is also a morale problem

The other side of the squeeze is the clinician workforce. Bain found that one in five doctors surveyed is actively considering switching organisations. Around 30% said recruitment and retention at their organisations have become more difficult since 2023.

The reasons matter. Doctors considering a move pointed mainly to excessive workloads, lack of recognition and burnout, rather than compensation. This is awkward for employers hoping that workforce strain can be solved mainly through pay packages. Pay may help, but Bain’s findings suggest that doctors are also asking for something more basic: the ability to do their jobs properly.

In both Australia and the Philippines, doctors ranked professional development and technology and tools as their most valued professional dimensions, ahead of compensation. Yet only about 30% said they were very satisfied with either.

Doctors in public systems appear to be under particular strain. Bain found that physicians in public hospitals reported significantly lower job advocacy than those in private hospitals. The report also found a strong relationship between clinician involvement and workplace advocacy: Asia-Pacific doctors who felt engaged in strategic decision-making reported employee Net Promoter Scores up to 36 points higher than those who did not.

That finding is easy to state and often hard to apply. Healthcare organisations frequently ask clinicians to adopt new systems, new tools and new models of care. Bain’s evidence suggests that adoption is likelier when doctors are involved in shaping the change, rather than receiving it as another administrative instruction. Doctors, it turns out, prefer not to be managed like inventory. A bold discovery.

A fragmented machine

Patients and doctors are both experiencing a system that often fails to connect its parts.

Half of the consumers Bain surveyed said they had been sent to multiple providers and locations before receiving the right diagnosis or treatment. More than 40% said they had received inconsistent advice from clinicians. The problem is worse for chronic patients: 55% said they had to see multiple doctors to fulfil their healthcare needs.

For patients, this means repeated explanations, duplicate steps and uncertainty about who is actually in charge. For doctors, it means lost time and administrative drag. About one in three doctors said they had observed significant waste and inefficiency in their organisations. Roughly 40% said they perform low-value, repetitive tasks that could be automated or simplified. Excessive forms and paperwork were a chief complaint.

Fragmentation also weakens the economic relationship between patients and providers. Bain found that patient experience strongly influences retention and future use of services. Patients who are “promoters” of their healthcare provider, based on Net Promoter Score, are 2.5 times more likely to stay with that provider and twice as likely to expand their use of services compared with detractors. In Indonesia, the Philippines and China, retention and increased share of wallet are up to four times higher for promoters.

Not every interaction has equal weight. Bain identified billing and coverage-related interactions as the strongest creators of detractors in Asia-Pacific, as well as among the lowest-performing experiences. In other words, a provider may invest heavily in clinical excellence only to lose goodwill at the payment desk. The bill, that small masterpiece of institutional communication, can still do great damage.

The search for one front door

The report’s clearest consumer signal is a desire for coordination. Ninety-five percent of consumers prefer a single touchpoint for managing their healthcare, up from 70% in 2019. More than 80% believe a primary care physician should serve as the first point of contact, maintaining longitudinal health history, guiding prevention and coordinating referrals.

Yet access to primary care is uneven. About a quarter of consumers in the region lack a primary care physician. The largest reported gaps are in Malaysia, at 39%, Hong Kong, at 38%, Indonesia, at 33%, and China, at 27%.

This creates a contest. If primary care cannot consistently act as the coordinating layer, another player may try. Bain names several possibilities: a specialist hub, pharmacy-led clinic network, payer-sponsored navigation platform or digital front door. The best model will differ by market. In China, for example, consumers are more likely than elsewhere in the region to prefer a digital app or hotline as the main coordination point. In most other markets, in-person interaction remains the preferred anchor.

Traditional providers still rank as the most trusted healthcare stakeholders overall, followed by governments, health insurers and pharmacies. But trust is shifting. Bain found that traditional providers’ relative trust ranking declined in China, Hong Kong, India, Indonesia, Singapore and Vietnam. Health insurers and health management organisations gained trust in Australia, Malaysia, the Philippines and Vietnam. Digital health companies became the third most trusted stakeholder in China, close behind hospitals and the government.

The lesson is not that hospitals and clinics are losing trust wholesale. They remain powerful. But other actors are gaining permission to participate in the patient journey. In a fragmented system, permission can become market share.

Care leaves the hospital, but not entirely

Asia-Pacific consumers are already using more care settings. Nearly 60% have received care in alternative settings such as walk-in clinics, patient homes, phones or wearables in the past 12 months.

The pattern differs across markets. Walk-in clinics in retail or pharmacy settings are the top alternative care sites in Malaysia, Australia and the Philippines. Walk-in and after-hours clinics lead in Indonesia and Hong Kong. Home-based care leads in India and Vietnam. Telehealth dominates in China and Singapore.

Doctors also support moving some care out of hospitals. In small specialty subsamples, surgeons said they would ideally perform 30-42% of procedures in ambulatory surgical centres, compared with 15-25% today. Clinicians cited patient preference as the main reason for shifting care to such settings. They also viewed ambulatory surgical centres as more willing to invest in advanced equipment and believed the shift could increase overall care volume.

Telehealth tells a more mixed story. Adoption doubled across Asia-Pacific between 2019 and 2021, then moderated everywhere except India and China. China was the upside outlier: telehealth penetration reached 61% in 2025, up 37 percentage points from 2019. India moved in the other direction, with telehealth penetration falling to 10%, below its 2019 baseline. Bain links this partly to India’s largely cash-pay market and limited payer-driven steering towards teleconsultations.

Despite digital adoption, most patients and doctors do not see telehealth as a full replacement for in-person care. Bain found that 70% of consumers and 65% of doctors view telehealth as a complement to physical consultations. Even in China, roughly 76% of consumers hold that view.

This is a useful correction to a common digital-health fantasy. The future of care is not simply online. It is distributed, with the right care in the right setting. Sometimes that means an app. Sometimes it means a clinic. Sometimes, stubbornly, it means a doctor in a room.

AI arrives before readiness

Artificial intelligence is the report’s most obvious technological theme, but Bain’s conclusion is restrained. Patients and doctors are increasingly open to AI-enabled care. Healthcare organisations, however, are not always ready to deploy it at scale.

Nearly 70% of Asia-Pacific consumers surveyed said they had used AI tools to better understand a diagnosis or treatment plan. Nearly three-quarters said they were comfortable with at least one AI-enabled healthcare application. Consumers were most comfortable with uses that support clinicians and improve efficiency, such as AI-assisted documentation, clinical decision support and automated analysis of medical exams and test results.

Support weakens when AI appears to replace human care. More than 35% of consumers said they were comfortable with AI-only call centres, medical advice, diagnoses and treatment plans, but in-person appointments remain the preferred channel for minor illness or non-acute symptoms such as a cold, sore throat or rash. Consumers were least likely to prefer chatbot-led diagnoses or treatment.

Doctors’ views are similar. They expect AI to reduce administrative burden and workload, but worry it could undermine the clinician-patient relationship. These concerns are not a rejection of technology. They are a warning about where technology should sit.

Bain found that about one in three doctors said their organisations are not prepared to deploy AI at scale. The barriers include unclear strategies, limited training and insufficient clinician involvement. This readiness gap is compounded by broader digital maturity constraints. Beyond telehealth, adoption of foundational digital tools remains limited across the region. Even in Australia, the report found low adoption of care management systems, workforce and workflow management tools, and revenue-cycle management solutions.

The report gives examples of AI use that has moved beyond novelty. Apollo Hospitals built a self-learning clinical decision support platform covering 1,300 conditions, maintained by more than 500 in-house clinicians. Singapore General Hospital’s PErioperative AI CHatbot, or PEACH, encodes perioperative guidelines into a large language model, helping clinicians triage preoperative patients, generate care plans and navigate more than 400 pages of guidelines with 98% documented accuracy. Across 25,000 preoperative patients, PEACH has saved an estimated 660 doctor hours annually. Ping An Good Doctor’s AI agents handle up to 4m consultation requests per day, reducing average service cost by roughly 52% per doctor, according to the report.

The common thread is not that AI was bolted on as a shiny feature. Bain stresses that high-impact examples rely on proprietary clinical assets and deliberate workflow redesign. AI works best when it changes how work is done. Used merely to decorate old processes, it risks becoming very expensive wallpaper.

The payment question

Rising costs remain one of the most persistent consumer pain points. Bain argues that healthcare systems need better ways to balance clinical outcomes with affordability, especially as ageing and chronic disease increase pressure.

That is why value-based care features prominently in the report. The term covers payment models that shift accountability from volume to value. Instead of rewarding more activity, these models aim to reward better outcomes, efficiency and affordability.

There is some momentum. Bain notes examples such as diagnosis-related groups and bundled payment adoption in China and India, as well as prevention-focused capitation through Singapore’s Healthier SG initiative. But most Asia-Pacific markets remain in the early-to-mid stages of value-based care adoption. Only a handful have begun embedding outcome-level or population-level accountability into payment architecture.

Clinicians are not the main obstacle. Fifty-six percent of doctors surveyed are more interested in value-based care models than they were two years ago. They cite potential benefits such as improved efficiency, higher patient satisfaction and better-quality care. But less than a third reported broad implementation of value-based payment models in their organisations.

Doctors also said they would be more willing to shift towards value-based models if there were evidence-based protocols, more reliable data systems and a lower reporting burden. That is a modest but important list. Value-based care cannot run on aspiration alone. It needs measurement, data and administrative designs that do not crush the clinicians expected to use them.

Who wins the relationship?

Bain’s implications for healthcare companies are direct. Providers, insurers and pharmacies all have openings. They also have risks.

For providers, the report says the patient relationship is the asset. Hospitals that remain focused on isolated procedures and inpatient volume may lose ground as consumers seek continuity through outpatient networks, primary care, diagnostics, pharmacy, day surgery and digital follow-up. The risk is not that hospitals vanish. It is that they become one stop in someone else’s care pathway.

For insurers, Bain’s warning is sharper: stop administering claims; start owning care. Insurers have an opportunity to become trusted healthcare coordinators, but only if they move beyond passive reimbursement. Billing and coverage questions are among the most damaging customer interactions. Fixing them is not administrative housekeeping. It is retention work.

For pharmacies, trust and reach create an opening. Bain notes that pharmacies rank among the top three most trusted stakeholders in Australia, India, Indonesia and the Philippines. They could become default entry points for routine and lower-acuity care by linking dispensing, screening, basic diagnostics and wellness services. But expansion alone is not enough. Pharmacies need integration with broader care pathways, referral relationships and secure data sharing.

Across all three groups, the common challenge is coordination. Consumers want fewer hand-offs. Doctors want fewer wasted steps. Organisations want loyalty and growth. The hard part is building the connective tissue.

The system between visits

The Bain report describes a healthcare system in transition. Patients are more informed, more demanding and more willing to spend on prevention and wellness. Doctors are more strained, more conscious of weak tools and more likely to consider leaving organisations that do not support them. AI is promising, but readiness is uneven. Care is moving outside hospitals, but not in a way that removes the need for human relationships.

The next phase will be decided between visits. That is where care is coordinated or lost, where bills confuse or reassure, where chronic patients are monitored or forgotten, and where clinicians either trust new tools or quietly work around them.

Asia-Pacific’s healthcare systems do not lack demand. They lack enough capacity, connection and organisational readiness to meet demand smoothly. The winners will be those that make healthcare easier to navigate without making it less human. The queue may not disappear. But it need not remain the region’s most reliable care coordinator.